AI Article Synopsis
- * He was treated with sublingual atropine eye drops, which reduced the need for intravenous atropine.
- * This treatment allowed for quick recovery, enabling him to walk without help and be discharged.
Article Abstract
An 89-year-old patient with fenitrothion toxicity received sublingual atropine eye drops, reducing the intravenous atropine requirement. This alternative method enabled rapid rehabilitation, and he walked unaided, leading to discharge.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11052684 | PMC |
| http://dx.doi.org/10.1002/ccr3.8762 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Parents Know Best: Uncovering a Rare Allergy During Anesthesia Consultation.
Case Rep Pediatr
December 2024
Department of Anesthesiology, Cliniques Universitaires Saint Luc, Bruxelles, Belgium.
Article Synopsis
- A 17-month-old child's scheduled surgery for plagiocephaly was postponed due to a past allergic reaction to atropine-based eye drops, prompting an allergy assessment.
- Skin tests confirmed an allergy to atropine, which is uncommon in pediatric anesthesia cases, highlighting the importance of thorough preoperative consultations.
- This case exemplifies the necessity of listening to parental concerns and the benefits of careful allergy testing to ensure a safe surgical experience.
Efficacy of defocus incorporated multiple segments (DIMS) lenses and low-dose atropine on retarding myopic shift among premyopic preschoolers: Protocol for a prospective, multicenter, randomized controlled trial.
PLoS One
December 2024
Department of Ophthalmology, Lotung Poh-Ai Hospital, Lo-Hsu Medical Foundation, Incorporation, Yilan, Taiwan.
Background: Myopia has been a rising problem globally. Early-onset myopia significantly increases the risk of high myopia later in life. Despite the proven benefits of increased outdoor time, optimal strategies for preventing early-onset myopia in premyopic children need further investigation.
View Article and Find Full Text PDFTwo-year changes of macular choroidal thickness in response to 0.01% atropine eye drops: Results from the myopia outcome study of atropine in children (MOSAIC) clinical trial.
Acta Ophthalmol
December 2024
Centre for Eye Research Ireland, Environmental Sustainability and Health Institute, Technological University Dublin, Dublin, Ireland.
Purpose: To investigate 2-year changes in macular choroidal thickness (ChT) in children receiving 0.01% atropine eyedrops and its relationship with spherical equivalent refraction (SER) progression and axial length (AL) elongation.
Methods: A total of 250 myopic children aged 6-16 years (167%-0.
Effectiveness of various atropine concentrations in myopia control for Asian children: a network meta-analysis.
Front Pharmacol
December 2024
Shenzhen Eye Institute, Shenzhen Eye Hospital, Jinan University, Shenzhen, Guangdong, China.
Objectives: To assess the effectiveness of various atropine concentrations in managing myopia among children in East, South, and Southeast Asia, and to determine the most effective concentration.
Methods: A systematic literature review was conducted using PubMed, Web of Science, Cochrane Library, and EMBASE. The search was limited to articles published up to 1 June 2024, and included studies in Chinese or English.
Proteomic analysis of effects of 1% atropine in myopia therapy in Guinea pigs.
Exp Eye Res
December 2024
Department of Preventative Ophthalmology, Shanghai Eye Disease Prevention and Treatment Center, Shanghai Eye Hospital, Shanghai, China. Electronic address:
Myopia is a significant global public health issue. Key interventions for managing myopia include atropine treatment, optical correction, and surgical methods. This study focused on evaluating alterations in retinal protein expression after atropine therapy for myopia.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!